Pharmalex Nordic ApS: Financial statements 2025
CVR: 37541540
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
Pharmalex Nordic ApS (CVR 37541540) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,533,803 and a net result of DKK 1,709,691 compared with DKK -88,447,652 the year before. That is a decrease of 13.5% compared with the year before. Equity in the 2025 report amounted to DKK -45,957,544. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,533,803
- Profit/Loss
- DKK 1,709,691
- Equity
- DKK -45,957,544
- Total Assets
- DKK 202,868,993
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.5M | 1.7M | -46M | 2 |
| 2024 | - | 4.1M | -88.4M | -47.7M | 2 |
| 2022 | - | 3.3M | 1.4M | 34.5M | 2 |
| 2021 | - | 3.4M | 4.9M | 33.1M | 2 |
| 2020 | - | 2.6M | 3.6M | 28.2M | 2 |
Official annual report
How creditworthy is Pharmalex Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmalex Nordic ApS has published its annual report for 2024. Gross profit came to DKK 4,083,048, and the net result was DKK -88,447,652.
About Pharmalex Nordic ApS
Pharmalex Nordic ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Åsa Pihlblad and Christopher Gauglitz. The company is owned by AmerisourceBergen International B.V.. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 3,533,803 and a net result of DKK 1,709,691 compared with DKK -88,447,652 the year before. Equity in the 2025 report amounted to DKK -45,957,544.